These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 32272921)

  • 1. Post hoc analysis of initial treatments and control status in the INITIAL study: an observational study of newly diagnosed patients with asthma.
    Lin J; Fu X; Jiang P; Song W; Hu X; Jie Z; Liu C; He Z; Zhou X; Tang H
    BMC Pulm Med; 2020 Apr; 20(1):87. PubMed ID: 32272921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. One-year follow up of asthmatic patients newly initiated on treatment with medium- or high-dose inhaled corticosteroid-long-acting β
    Buhl R; Heaney LG; Loefroth E; Larbig M; Kostikas K; Conti V; Cao H
    Respir Med; 2020 Feb; 162():105859. PubMed ID: 31916534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Addition to inhaled corticosteroids of long-acting beta2-agonists versus anti-leukotrienes for chronic asthma.
    Ducharme FM; Lasserson TJ; Cates CJ
    Cochrane Database Syst Rev; 2011 May; (5):CD003137. PubMed ID: 21563136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retrospective, observational study of different medication regimens and outcome in children with cough variant asthma.
    Lou N; Ma X; Luo Q; Wei X; Zhang Y; Guo J; Wang J; Gai Z
    Immun Inflamm Dis; 2024 Aug; 12(8):e1357. PubMed ID: 39110093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthma.
    Ram FS; Cates CJ; Ducharme FM
    Cochrane Database Syst Rev; 2005 Jan; (1):CD003137. PubMed ID: 15674901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between previous health care use and initiation of inhaled corticosteroid and long-acting beta2-adrenergic agonist combination therapy among US patients with asthma.
    Blanchette CM; Culler SD; Ershoff D; Gutierrez B
    Clin Ther; 2009 Nov; 31(11):2574-83. PubMed ID: 20110003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthma.
    Ducharme FM; Lasserson TJ; Cates CJ
    Cochrane Database Syst Rev; 2006 Oct; (4):CD003137. PubMed ID: 17054161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prescribing patterns of asthma controller therapy for children in UK primary care: a cross-sectional observational study.
    Thomas M; Murray-Thomas T; Fan T; Williams T; Taylor S
    BMC Pulm Med; 2010 May; 10():29. PubMed ID: 20470409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economic Burden Associated with Receiving Inhaled Corticosteroids with Leukotriene Receptor Antagonists or Long-Acting Beta Agonists as Combination Therapy in Older Adults.
    Altawalbeh SM; Thorpe CT; Zgibor JC; Kane-Gill S; Kang Y; Thorpe JM
    J Manag Care Spec Pharm; 2018 May; 24(5):478-486. PubMed ID: 29694289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of asthma control and lung function responsiveness to step 3 therapy in children with uncontrolled asthma.
    Rabinovitch N; Mauger DT; Reisdorph N; Covar R; Malka J; Lemanske RF; Morgan WJ; Guilbert TW; Zeiger RS; Bacharier LB; Szefler SJ
    J Allergy Clin Immunol; 2014 Feb; 133(2):350-6. PubMed ID: 24084071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-Utility Analysis of Long-Acting Beta Agonists versus Leukotriene Receptor Antagonists in Older Adults with Persistent Asthma Receiving Concomitant Inhaled Corticosteroid Therapy.
    Altawalbeh SM; Thorpe JM; Thorpe CT; Smith KJ
    Value Health; 2016; 19(5):537-43. PubMed ID: 27565270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of drug treatment strategies to prevent asthma exacerbations and increase symptom-free days in asthmatic children: a network meta-analysis.
    Zhao Y; Han S; Shang J; Zhao X; Pu R; Shi L
    J Asthma; 2015 Oct; 52(8):846-57. PubMed ID: 26061910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Addition of leukotriene receptor antagonists to inhaled corticosteroids improved QOL of patients with bronchial asthma surveyed in suburban Tokyo, Japan.
    Ohshima N; Matsui H; Matsui Y; Kawashima M; Shimada M; Higaki N; Shoji S; Wada H; Fujita A; Watanabe H; Yamaguchi N; Matsuoka R; Oki K; Takahashi H; Suzuki M; Yamazaki H; Yoshizawa M; Goto H
    Allergol Int; 2011 Dec; 60(4):473-81. PubMed ID: 21681017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. INITIAL - An observational study of disease severity in newly diagnosed asthma patients and initial response following 12 weeks' treatment.
    Lin J; Fu X; Jiang P; Song W; Hu X; Jie Z; Liu C; He Z; Zhou X; Tang H
    Sci Rep; 2019 Feb; 9(1):1254. PubMed ID: 30718519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Appropriate use of inhaled corticosteroid and long-acting beta(2)-adrenergic agonist combination therapy among asthma patients in a US commercially insured population.
    Ye X; Gutierrez B; Zarotsky V; Nelson M; Blanchette CM
    Curr Med Res Opin; 2009 Sep; 25(9):2251-8. PubMed ID: 19622006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of leukotriene receptor antagonists in addition to inhaled corticosteroid and inhaled corticosteroid alone in the treatment of adolescents and adults with bronchial asthma: a meta-analysis.
    Cao Y; Wang J; Bunjhoo H; Xie M; Xu Y; Fang H
    Asian Pac J Allergy Immunol; 2012 Jun; 30(2):130-8. PubMed ID: 22830292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-acting beta-2 agonist prescription patterns and clinical outcomes in Chinese patients with asthma: an observational study in mainland China for the SABINA programme.
    Bao W; Zhang Y; Hang J; Guo Y; Tang W; Yun C; Deng J; Jin M; Lai K; Yu H; Beekman M; Zhou X; Zhang M
    Ther Adv Respir Dis; 2022; 16():17534666221115054. PubMed ID: 36065527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of once-daily fluticasone furoate/vilanterol (FF/VI) versus twice-daily inhaled corticosteroids/long-acting β
    Devillier P; Humbert M; Boye A; Zachgo W; Jacques L; Nunn C; West S; Nicholls A; Antoun Z; Spinu L; Grouin JM
    Respir Med; 2018 Aug; 141():111-120. PubMed ID: 30053956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Addition of inhaled long-acting beta2-agonists to inhaled steroids as first line therapy for persistent asthma in steroid-naive adults.
    Ni CM; Greenstone IR; Ducharme FM
    Cochrane Database Syst Rev; 2005 Apr; (2):CD005307. PubMed ID: 15846751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Montelukast or salmeterol combined with an inhaled steroid in adult asthma: design and rationale of a randomized, double-blind comparative study (the IMPACT Investigation of Montelukast as a Partner Agent for Complementary Therapy-trial).
    Bjermer L; Bisgaard H; Bousquet J; Fabbri LM; Greening A; Haahtela T; Holgate ST; Picado C; Leff JA
    Respir Med; 2000 Jun; 94(6):612-21. PubMed ID: 10921768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.